IGI LABS INC
GenericsIGI LABS INC is a generic drug manufacturer focused on Dermatology.
IGI LABS INC's Key Drugs
IGI LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
IGI LABS INC's Recent FDA Approvals
New NDA/BLA approvals for IGI LABS INC over the last two years — novel drugs only, excluding generics and label supplements.
IGI LABS INC's Therapeutic Areas
IGI LABS INC's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
IGI LABS INC's Top Competitors
IGI LABS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
IGI LABS INC Pipeline Snapshot
Active clinical trials for IGI LABS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1985-10-23
- Latest
- 2002-07-17
- Applications
- 53